Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Condensed Consolidated Statements of Operations
Net sales	$ 808,011	$ 541,675	$ 1,432,894	$ 1,007,352
Cost of products sold	(738,342)	(512,107)	(1,322,083)	(948,275)
Gross profit	69,669	29,568	110,811	59,077
Selling, general and administrative expenses	(62,474)	(27,485)	(98,777)	(51,024)
Income from operations	7,195	2,083	12,034	8,053
Other income (expense):
Interest expense	(1,903)	(365)	(2,224)	(895)
Change in fair value of redeemable common shares		957		957
Equity loss of non-consolidated entity		(309)		(710)
Other	75	49	179	517
Total other (expense) income	(1,828)	332	(2,045)	(131)
Income before income taxes	5,367	2,415	9,989	7,922
Income tax expense	(2,254)	(740)	(4,204)	(4,557)
Net income	3,113	1,675	5,785	3,365
Less net loss attributable to noncontrolling interest	(277)		(464)
Net income attributable to Diplomat Pharmacy, Inc.	3,390	1,675	6,249	3,365
Net income allocable to preferred shareholders		299		401
Net income allocable to common shareholders	$ 3,390	$ 1,376	$ 6,249	$ 2,964
Net income per common share:
Basic (in dollars per share)	$ 0.05	$ 0.04	$ 0.11	$ 0.09
Diluted (in dollars per share)	$ 0.05	$ 0.04	$ 0.10	$ 0.09
Weighted average common shares outstanding:
Basic (in shares)	62,610,850	30,748,750	57,279,670	31,400,210
Diluted (in shares)	64,795,362	33,304,028	59,845,620	34,101,120